Anglo American is conducting an “impairment review” of its De Beers business due to poor conditions in the diamond market and preparing to write down the unit’s value ahead of a planned demerger.

AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter 2024. The London-listed company ...